Home › Cardiovascular Disease › Virginia › Arlington
Cardiovascular Disease clinical trials in Arlington, VA
13 studies for Cardiovascular Disease are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Carient Heart and Vascular LLC-Reston, Reston · 14 mi away
- Carient Heart & Vascular - Manassas, Manassas · 22 mi away
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
- Virginia Heart, Falls Church · 4 mi away
Product Surveillance Registry
RecruitingObservational study
- Falls Church, Falls Church · 4 mi away
- Fairfax, Fairfax · 11 mi away
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Arlington
- Clinical Trial Site, Falls Church · 4 mi away
- Clinical Trial Site, Fairfax · 11 mi away
- and 1 more
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Seven Corners Medical Center, Falls Church · 4 mi away
- Carient Heart and Vascular, Manassas · 22 mi away
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Inova Fairfax Hospital, Fairfax · 11 mi away
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Recruiting
- Inova Fairfax Medical Campus, Falls Church · 4 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Inova Fairfax Hospital, Falls Church · 4 mi away
- Virginia Heart, Falls Church · 4 mi away
- Carient Heart and Vascular, Manassas · 22 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Falls Church · 4 mi away
- Research Site, Fairfax · 11 mi away
- Research Site, Manassas · 22 mi away
- and 1 more
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Virginia Heart, Falls Church · 4 mi away
- Inova Cardiology - Fairfax, Fairfax · 11 mi away
- Carient Heart and Vascular, Manassas · 22 mi away
Global Paradise System US Post Approval Study
RecruitingObservational study
- Inova Fairfax Hospital, Fairfax · 11 mi away
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RecruitingPhase 3
- Virginia Heart, Falls Church · 4 mi away
ELEVATE-HFpEF Clinical Study
Recruiting
- Inova Fairfax Hospital, Falls Church · 4 mi away
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN19 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)49 studies
- Breast Cancer46 studies
- Ovarian Cancer45 studies
- Lung Cancer40 studies
- Endometrial Cancer38 studies
- Pancreatic Cancer35 studies
- Head and Neck Squamous Cell Carcinoma25 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.